EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 344 filers reported holding EXELIXIS INC in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $44,046,060 | +21.8% | 2,015,838 | +6.0% | 0.09% | +18.2% |
Q2 2023 | $36,148,865 | -18.5% | 1,901,571 | -18.6% | 0.08% | -20.6% |
Q1 2023 | $44,340,478 | +7.7% | 2,337,400 | -11.0% | 0.10% | +3.2% |
Q4 2022 | $41,172,002 | +54.3% | 2,626,603 | +54.3% | 0.09% | +44.6% |
Q3 2022 | $26,689,000 | -34.1% | 1,702,103 | -13.4% | 0.06% | -29.3% |
Q2 2022 | $40,493,000 | +105.5% | 1,964,719 | +124.4% | 0.09% | +148.6% |
Q1 2022 | $19,700,000 | +127.6% | 875,550 | +84.9% | 0.04% | +131.2% |
Q4 2021 | $8,654,000 | +40.1% | 473,423 | +61.2% | 0.02% | +45.5% |
Q3 2021 | $6,176,000 | +151.3% | 293,689 | +114.6% | 0.01% | +175.0% |
Q2 2021 | $2,458,000 | -69.8% | 136,867 | -62.1% | 0.00% | -69.2% |
Q1 2021 | $8,132,000 | -67.4% | 360,778 | -71.4% | 0.01% | -70.5% |
Q4 2020 | $24,948,000 | -53.6% | 1,259,979 | -42.7% | 0.04% | -51.6% |
Q3 2020 | $53,745,000 | -35.0% | 2,198,148 | -38.6% | 0.09% | -32.1% |
Q2 2020 | $82,715,000 | -13.6% | 3,582,299 | -35.5% | 0.13% | -16.8% |
Q1 2020 | $95,709,000 | -28.6% | 5,558,004 | -26.9% | 0.16% | +5.9% |
Q4 2019 | $134,001,000 | -38.8% | 7,605,038 | -38.6% | 0.15% | -41.1% |
Q3 2019 | $218,991,000 | -25.2% | 12,382,888 | -9.6% | 0.26% | -20.9% |
Q2 2019 | $292,618,000 | -22.4% | 13,692,954 | -13.6% | 0.33% | -18.5% |
Q1 2019 | $377,291,000 | +77.1% | 15,852,556 | +46.4% | 0.40% | +61.9% |
Q4 2018 | $213,048,000 | +306.2% | 10,831,112 | +266.0% | 0.25% | +394.0% |
Q3 2018 | $52,443,000 | -44.6% | 2,959,487 | -32.8% | 0.05% | -47.4% |
Q2 2018 | $94,729,000 | -42.8% | 4,401,907 | -41.1% | 0.10% | -46.9% |
Q1 2018 | $165,562,000 | -25.7% | 7,474,604 | +2.0% | 0.18% | -23.5% |
Q4 2017 | $222,708,000 | +52.7% | 7,325,932 | +21.7% | 0.23% | +34.5% |
Q3 2017 | $145,815,000 | +317.7% | 6,017,941 | +324.6% | 0.17% | +278.3% |
Q2 2017 | $34,907,000 | +101.6% | 1,417,247 | +77.4% | 0.05% | +100.0% |
Q1 2017 | $17,312,000 | +124.3% | 798,904 | +54.3% | 0.02% | +109.1% |
Q4 2016 | $7,719,000 | +44.4% | 517,660 | +23.8% | 0.01% | +37.5% |
Q3 2016 | $5,347,000 | +176.0% | 418,043 | +68.6% | 0.01% | +166.7% |
Q2 2016 | $1,937,000 | +403.1% | 247,978 | +157.3% | 0.00% | +200.0% |
Q1 2016 | $385,000 | -75.0% | 96,364 | -64.7% | 0.00% | -66.7% |
Q4 2015 | $1,541,000 | +55.0% | 273,091 | +54.1% | 0.00% | +50.0% |
Q3 2015 | $994,000 | +1811.5% | 177,267 | +1107.4% | 0.00% | – |
Q1 2014 | $52,000 | +5100.0% | 14,682 | +8194.9% | 0.00% | – |
Q4 2012 | $1,000 | – | 177 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |